Literature DB >> 21503677

Serum vitamin D concentrations and unexplained elevation in ALT among US adults.

Suthat Liangpunsakul1, Naga Chalasani.   

Abstract

BACKGROUND: Low serum levels of vitamin D are associated with metabolic syndrome. Participants in NHANES III with unexplained elevation in ALT levels have high prevalence of metabolic syndrome. We hypothesized that the serum concentrations of vitamin D were inversely associated with unexplained elevation in ALT.
METHODS: A total of 6,826 fasting subjects underwent morning physical examination and met the inclusion and exclusion criteria. From these participants, we have constructed cases with unexplained elevation in ALT (n = 308) and compared their serum vitamin D concentrations to matched controls with normal ALT (N = 979). We examined the prevalence of unexplained elevation in ALT level across different quartiles of vitamin D levels.
RESULTS: Participants with unexplained elevation in ALT had significantly lower serum vitamin D levels compared to controls (61.8 ± 26.0 nmol/l vs. 66.8 ± 27.1 nmol/l, P < 0.01). The unadjusted prevalence of unexplained elevation in ALT in patients with highest to lowest quartiles of serum vitamin D levels were 21.4, 21.4, 25.6, and 31.5%, respectively. Compared to lowest quartile, patients with top two quartiles of serum vitamin D levels had significantly lower prevalence of unexplained elevation in ALT (OR, 95% CI for highest quartile 0.62 [0.43-0.89] and for third quartile 0.61 [0.42-0.86]). This relationship persisted even after controlling for metabolic syndrome, insulin resistance, and serum triglycerides.
CONCLUSIONS: This study suggests a significant inverse relationship between serum vitamin D levels and unexplained elevation in ALT. Further studies are needed to confirm this observation and to understand the basis for and implications of this observation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21503677      PMCID: PMC3644216          DOI: 10.1007/s10620-011-1707-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  16 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Serum 25-hydroxyvitamin D response to oral vitamin D intake in children.

Authors:  Armin Zittermann
Journal:  Am J Clin Nutr       Date:  2003-09       Impact factor: 7.045

3.  Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults.

Authors:  Earl S Ford; Umed A Ajani; Lisa C McGuire; Simin Liu
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

4.  The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages.

Authors:  Merav Cohen-Lahav; Amos Douvdevani; Cidio Chaimovitz; Shraga Shany
Journal:  J Steroid Biochem Mol Biol       Date:  2006-12-23       Impact factor: 4.292

5.  Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III).

Authors:  Suthat Liangpunsakul; Naga Chalasani
Journal:  Am J Med Sci       Date:  2005-03       Impact factor: 2.378

6.  Influence of season, ethnicity, and chronicity on vitamin D deficiency in traumatic spinal cord injury.

Authors:  Christina V Oleson; Payal H Patel; Lisa-Ann Wuermser
Journal:  J Spinal Cord Med       Date:  2010       Impact factor: 1.985

7.  25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey.

Authors:  M Chonchol; R Scragg
Journal:  Kidney Int       Date:  2006-11-01       Impact factor: 10.612

8.  Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction.

Authors:  Ken C Chiu; Audrey Chu; Vay Liang W Go; Mohammed F Saad
Journal:  Am J Clin Nutr       Date:  2004-05       Impact factor: 7.045

9.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

10.  Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States.

Authors:  Constance E Ruhl; James E Everhart
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

View more
  24 in total

1.  Histamine H2-Receptor Antagonist Use Is Associated With Lower Prevalence of Nonalcoholic Fatty Liver Disease: A Population-based Study From the National Health and Nutrition Examination Survey, 2001-2006.

Authors:  Huafeng Shen; Suthat Liangpunsakul
Journal:  J Clin Gastroenterol       Date:  2016-08       Impact factor: 3.062

2.  Serum vitamin D concentrations and unexplained elevation in ALT among US adults.

Authors:  Barbara J Boucher
Journal:  Dig Dis Sci       Date:  2011-08       Impact factor: 3.199

Review 3.  Metabolic syndrome: A review of the role of vitamin D in mediating susceptibility and outcome.

Authors:  Richard C Strange; Kate E Shipman; Sudarshan Ramachandran
Journal:  World J Diabetes       Date:  2015-07-10

4.  Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial.

Authors:  Nasrin Sharifi; Reza Amani; Eskandar Hajiani; Bahman Cheraghian
Journal:  Endocrine       Date:  2014-06-27       Impact factor: 3.633

5.  Vitamin D is Not Associated With Severity in NAFLD: Results of a Paired Clinical and Gene Expression Profile Analysis.

Authors:  Yuval A Patel; Ricardo Henao; Cynthia A Moylan; Cynthia D Guy; Dawn L Piercy; Anna Mae Diehl; Manal F Abdelmalek
Journal:  Am J Gastroenterol       Date:  2016-09-20       Impact factor: 10.864

Review 6.  Vitamin D: a new player in non-alcoholic fatty liver disease?

Authors:  Myrto Eliades; Elias Spyrou
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

Review 7.  Vitamin d deficiency in patients with chronic liver disease and cirrhosis.

Authors:  Lei Yuan Lim; Naga Chalasani
Journal:  Curr Gastroenterol Rep       Date:  2012-02

8.  PATHOGENESIS OF HEPATOCELLULAR CARCINOMA DEVELOPMENT IN NON ALCOHOLIC FATTY LIVER DISEASE.

Authors:  Kirti Shetty; Jian Chen; Ji-Hyun Shin; Wilma Jogunoori; Lopa Mishra
Journal:  Curr Hepatol Rep       Date:  2015-06

9.  Serum vitamin D is associated with non-alcoholic fatty liver disease in Chinese males with normal weight and liver enzymes.

Authors:  Ya-ping Hao; Xiao-jing Ma; Yu-qi Luo; Jie Ni; Jian-xin Dou; Ya-qin Hu; Jia-an Zhu; Yu-qian Bao; Wei-ping Jia
Journal:  Acta Pharmacol Sin       Date:  2014-08-04       Impact factor: 6.150

10.  Prevalence and morbidity associated with muscle cramps in patients with cirrhosis.

Authors:  Hemant Chatrath; Suthat Liangpunsakul; Marwan Ghabril; Julie Otte; Naga Chalasani; Raj Vuppalanchi
Journal:  Am J Med       Date:  2012-07-24       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.